Page 25 - AN-3-2

Advanced Neurology Fatigue management in patients with MS

Availability of data 11. Jhonson SL. The concept of fatigue in multiple sclerosis.
J Neurosci Nurs. 2008;40(2):77-78.
Not applicable.
doi: 10.1097/01376517-200804000-00005
References 12. Manjaly ZM, Harrison NA, Critchley HD, et al.

1. McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis Pathophysiological and cognitive mechanisms of fatigue
and treatment of multiple sclerosis. JAMA. 2021;325(8):765. in multiple sclerosis. J Neurol Neurosurg Psychiatry.
2019;90(6):642-651.
doi: 10.1001/jama.2020.26858
doi: 10.1136/jnnp-2018-320050
2. Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis:
Pathogenesis, symptoms, diagnoses and cell-based therapy. 13. Nourbakhsh B, Azevedo C, Nunan-Saah J, et al. Longitudinal
Cell J. 2017;19(1):1-10. associations between brain structural changes and fatigue in
early MS. Mult Scler Relat Disord. 2016;5:29-33.
doi: 10.22074/cellj.2016.4867
doi: 10.1016/j.msard.2015.10.006
3. Huang WJ, Chen WW, Zhang X. Multiple sclerosis:
Pathology, diagnosis and treatments. Exp Ther Med. 14. Rocca MA, Parisi L, Pagani E, et al. Regional but not global
2017;13(6):3163-3166. brain damage contributes to fatigue in multiple sclerosis.
Radiology. 2014;273(2):511-520.
doi: 10.3892/etm.2017.4410
doi: 10.1148/radiol.14140417
4. Hauser SL, Cree BAC. Treatment of multiple sclerosis:
A review. Am J Med. 2020;133(12):1380-1390.e2. 15. Calabrese M, Rinaldi F, Grossi P, et al. Basal ganglia and
frontal/parietal cortical atrophy is associated with fatigue
doi: 10.1016/j.amjmed.2020.05.049 in relapsing- remitting multiple sclerosis. Mult Scler J.
5. Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. 2010;16(10):1220-1228.
Comprehensive approach to management of multiple doi: 10.1177/1352458510376405
sclerosis: Addressing invisible symptoms-a narrative review.
Neurol Ther. 2021;10(1):75-98. 16. Cruz Gómez ÁJ, Ventura Campos N, Belenguer A, Ávila C,
Forn C. Regional brain atrophy and functional connectivity
doi: 10.1007/s40120-021-00239-2 changes related to fatigue in multiple sclerosis. PLoS One.
6. Ayache SS, Chalah MA. Fatigue in multiple sclerosis - insights 2013;8(10):e77914.
into evaluation and management. Neurophysiol Clin. doi: 10.1371/journal.pone.0077914
2017;47(2):139-171.
17. Qiu W, Raven S, Wu JS, et al. Hypothalamic lesions in multiple
doi: 10.1016/j.neucli.2017.02.004 sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(7):819-822.
7. Dilek F, Bitek DE, Erol Ö, Ünsar S. Three symptoms doi: 10.1136/jnnp.2009.198192
and nursing management of multiple sclerosis: Fatigue,
bladder problems and sexuality. J Anatolia Nurs Health Sci. 18. Huitinga I, Erkut ZA, van Beurden D, Swaab DF. Impaired
2019;22(4):300-305. hypothalamus‐pituitary‐adrenal axis activity and more
severe multiple sclerosis with hypothalamic lesions. Ann
doi: 10.17049/ataunihem.431464 Neurol. 2004;55(1):37-45.
8. Derle E, Uzuner N, Canbaz Kabay S, Tuncer MA. Multipl doi: 10.1002/ana.10766
skleroz sürecinde izlenen semptomlar ve tedavi yaklaşimlari
(Symptoms and treatment approaches during the multiple 19. Oliva Ramirez A, Keenan A, Kalau O, Worthington E,
sclerosis process). In: Efendi H, Yandım Kuşcu D, editors. Cohen L, Singh S. Prevalence and burden of multiple
Multipl Skleroz Tanı ve Tedavi Kılavuzu (Multiple Sclerosis sclerosis-related fatigue: A systematic literature review. BMC
Diagnosis and Treatment Guide). Türkiye: Galenos Yayınevi; Neurol. 2021;21(1):468.
2018. p. 152-153. doi: 10.1186/s12883-021-02396-1
9. Patejdl R, Zettl UK. The pathophysiology of motor 20. Rottoli M, La Gioia S, Frigeni B, Barcella V. Pathophysiology,
fatigue and fatigability in multiple sclerosis. Front Neurol. assessment and management of multiple sclerosis fatigue:
2022;13:891415. An update. Expert Rev Neurother. 2017;17(4):373-379.
doi: 10.3389/fneur.2022.891415 doi: 10.1080/14737175.2017.1247695
10. Ayache SS, Serratrice N, Abi Lahoud GN, Chalah MA. 21. Krupp LB, Larocca NG, Muir Nash J, Steinberg AD. The
Fatigue in multiple sclerosis: A review of the exploratory fatigue severity scale: Application to patients with multiple
and therapeutic potential of non-invasive brain stimulation. sclerosis and systemic lupus erythematosus. Arch Neurol.
Front Neurol. 2022;13:813965. 1989;46(10):1121-1123.
doi: 10.3389/fneur.2022.813965 doi: 10.1001/archneur.1989.00520460115022

Volume 3 Issue 2 (2024) 8 doi: 10.36922/an.2576